20.08.2024 13:28:15
|
CollPlant Biotechnologies Posts Loss In Q2 - Quick Facts
(RTTNews) - CollPlant Biotechnologies (CLGN) posted a second quarter net loss of $4.21 million or $0.37 per share compared to profit of $5.76 million or $0.49 per share, a year ago. Non-GAAP net loss was $3.8 million, or $0.33 per share, compared to net income of $6.0 million, or $0.53 basic per share, prior year.
Revenue was $249 thousand compared to $10.18 million. The company said the decrease in revenues is mainly related to the achievement of a milestone with respect to the AbbVie agreement, which triggered a $10 million payment in 2023.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Collplant Holdings Ltd.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Collplant Holdings Ltd.mehr Analysen
Aktien in diesem Artikel
Collplant Holdings Ltd. | 4,40 | -2,65% |
|